Literature DB >> 26561064

Chronic Inflammatory Diseases: Progress and Prospect with Herbal Medicine.

Nilanjan Ghosh, Asif Ali, Rituparna Ghosh, Shaileyee Das, Subhash C Mandal, Mahadeb Pal1.   

Abstract

Diseases associated with chronic inflammatory pathology claim a major share of worldwide deaths each year. A principal reason behind the huge number of casualties is associated with mild or unnoticed symptoms for long period of time since the outset, and that specific treatment options for these diseases have not yet emerged. Current anti-inflammatory drugs essentially have become ineffective for long term protection from these diseases as they also interfere with essential cellular pathways and associated toxicities. Notably, recent studies with a number of phytochemicals have shown promising results. These compounds isolated from various medicinal plants express their anti-inflammatory activities by down regulating expression of several crucial pro-inflammatory mediators. These are mostly antioxidants; inhibit induction of key transcription factors like nuclear factor kappa B (NF-κB) that are responsible for expression of proinflammatory mediators, and other growth regulators. Definitely, some of these compounds have the potential to be developed into new therapeutic agents to better control inflammation associated diseases in near future. This review summarizes recent findings on the molecular mechanisms through which various inflammatory activities are linked to disease progression and a group of natural products that have shown promise in controlling these processes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26561064     DOI: 10.2174/1381612822666151112151419

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  6 in total

1.  Antinociceptive and anti-inflammatory activities of the Jatropha isabellei dichloromethane fraction and isolation and quantitative determination of jatrophone by UFLC-DAD.

Authors:  Janaina Kieling Fröhlich; Taciane Stein; Layzon Antônio da Silva; Maique Weber Biavatti; Carlos Rogério Tonussi; Elenara Lemos-Senna
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

2.  Rapid Screening of Active Components with an Osteoclastic Inhibitory Effect in Herba epimedii Using Quantitative Pattern-Activity Relationships Based on Joint-Action Models.

Authors:  Xiao-Yan Yuan; Meng Wang; Sheng Lei; Qian-Xu Yang; Yan-Qiu Liu
Journal:  Molecules       Date:  2017-10-19       Impact factor: 4.411

3.  Evaluation of LPS-Induced Acute Lung Injury Attenuation in Rats by Aminothiazole-Paeonol Derivatives.

Authors:  Pin-Kuei Fu; Chi-Yu Yang; Su-Chin Huang; Yu-Wen Hung; Kee-Ching Jeng; Ying-Pei Huang; Hong Chuang; Nai-Chun Huang; Jui-Ping Li; Ming-Hua Hsu; Jen-Kun Chen
Journal:  Molecules       Date:  2017-09-25       Impact factor: 4.411

4.  Standardised comparison of limonene-derived monoterpenes identifies structural determinants of anti-inflammatory activity.

Authors:  Cátia Sousa; Alcino Jorge Leitão; Bruno Miguel Neves; Fernando Judas; Carlos Cavaleiro; Alexandrina Ferreira Mendes
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

Review 5.  Prostate cancer: Therapeutic prospect with herbal medicine.

Authors:  Suvranil Ghosh; Joyita Hazra; Koustav Pal; Vinod K Nelson; Mahadeb Pal
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-07-08

Review 6.  Resveratrol from Dietary Supplement to a Drug Candidate: An Assessment of Potential.

Authors:  Shivani Khattar; Sauban Ahmed Khan; Syed Amir Azam Zaidi; Mahdi Darvishikolour; Uzma Farooq; Punnoth Poonkuzhi Naseef; Mohamed Saheer Kurunian; Mohammed Zaafar Khan; Athar Shamim; Mohd Masih Uzzaman Khan; Zeenat Iqbal; Mohd Aamir Mirza
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.